Effects of the cannabinoid receptor antagonist, AM251, on the cardiovascular responses to the cannabinoid receptor agonist, WIN 55212-2, and to anandamide, in conscious rats

被引：0
|
作者：
Gardiner, SM [1 ]
March, JE [1 ]
Kemp, PA [1 ]
Bennett, T [1 ]
机构：
[1] Queens Med Ctr, Sch Biomed Sci, Nottingham NG7 2UH, England
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 2002年 / 135卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
37P
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Cannabinoid Receptor Type 1 Antagonist, AM251, Attenuates Mechanical Allodynia and Thermal Hyperalgesia after Burn Injury
    Ueda, Masashi
    Iwasaki, Hajime
    Wang, Shuxing
    Murata, Eri
    Poon, K. Y. Trudy
    Mao, Jianren
    Martyn, J. A. Jeevendra
    [J]. ANESTHESIOLOGY, 2014, 121 (06) : 1311 - 1319
  • [42] Acute effects of endocannabinoid anandamide and CB1 receptor antagonist, AM251 in the regulation of thyrotropin secretion
    Liberato Costa da Veiga, Marco Aurelio
    Bloise, Flavia Fonseca
    Costa-e-Sousa, Ricardo Henrique
    Souza, Luana Lopes
    dos Santos Almeida, Norma Aparecida
    Oliveira, Karen Jesus
    Pazos-Moura, Carmen Cabanelas
    [J]. JOURNAL OF ENDOCRINOLOGY, 2008, 199 (02) : 235 - 242
  • [43] Cannabinoid Type 1 Receptor Antagonist, Am251, Prevents Attenuation Of Serotonin-Induced Apneas By Dronabinol In Sprague-Dawley Rats
    Calik, M. W.
    Radulovacki, M.
    Carley, D. W.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [44] Cannabinoid CB1 receptor antagonist AM251 inhibits cocaine-primed relapse in rats:: Role of glutamate in the nucleus accumbens
    Xi, Zheng-Xiong
    Gilbert, Jeremy G.
    Peng, Xiao-Qing
    Pak, Arlene C.
    Li, Xia
    Gardner, Eliot L.
    [J]. JOURNAL OF NEUROSCIENCE, 2006, 26 (33): : 8531 - 8536
  • [45] Synthesis and characterization of the potent cannabinoid agonist [naphthyl-3H] WIN 55212-2 at high specific activity
    Seguin, RJ
    Filer, CN
    [J]. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2003, 46 (01): : 67 - 71
  • [46] Identification of WIN55212-3 as a competitive neutral antagonist of the human cannabinoid CB2 receptor
    Savinainen, JR
    Kokkola, T
    Salo, OMH
    Poso, A
    Järvinen, T
    Laitinen, JT
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2005, 145 (05) : 636 - 645
  • [47] Effects of the CB1 cannabinoid receptor inverse agonist AM251 on food intake and body weight in mice lacking μ-opioid receptors
    Chen, Richard Z.
    Frassetto, Andrea
    Fong, Tung M.
    [J]. BRAIN RESEARCH, 2006, 1108 : 176 - 178
  • [48] The cannabinoid receptor CB1 inverse agonist AM251 potentiates the anxiogenic activity of urocortin I in the basolateral amygdala
    Dono, Lindsey M.
    Currie, Paul J.
    [J]. NEUROPHARMACOLOGY, 2012, 62 (01) : 192 - 199
  • [49] THE CANNABINOID 1 RECEPTOR ANTAGONIST AM251 ALTERS THE KYOTORPHIN EFFECT ON DENSITY OF CB1 IMMUNOPOSITIVE NEURONS IN THE AMYGDALA
    Landzhov, Boycho
    Malinova, Lina
    Kartelov, Yuliyan
    Dzhambazova, Elena
    Ovtscharoff, Wladimir
    [J]. COMPTES RENDUS DE L ACADEMIE BULGARE DES SCIENCES, 2014, 67 (08): : 1165 - 1170
  • [50] Ultra-low dose cannabinoid antagonist AM251 enhances cannabinoid anticonvulsant effects in the pentylenetetrazole-induced seizure in mice
    Gholizadeh, Shervin
    Shafaroodi, Hamed
    GhaseMi, Mehdi
    Bahremand, Arash
    Sharifzadeh, Mohammad
    Dehpour, Ahmad Reza
    [J]. NEUROPHARMACOLOGY, 2007, 53 (06) : 763 - 770
12345